EYEN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
EYEN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.
Michael M Rowe | director, officer: Chief Executive Officer | C/O EYENOVIA, INC., 501 FIFTH AVENUE, SUITE 1404, NEW YORK NY 10017 |
Stuart M. Grant | 10 percent owner | 11 SUMMIT LANE, GREENVILLE DE 19807 |
Ellen R Strahlman | director | ALTRIA GROUP, INC., 6601 W. BROAD STREET, RICHMOND VA 23230 |
Ram Palanki | director | C/O EYENOVIA, INC, 295 MADISON AVENUE SUITE 2400, NEW YORK NY 10017 |
Rachel Jacobson | director | C/O EYENOVIA INC, 295 MADISON AVENUE SUITE 2400, NEW YORK NY 10017 |
John P Gandolfo | officer: Chief Financial Officer | 62 TERRACE ROAD, WAYNE NJ 07470 |
Bren Kern | officer: Chief Operating Officer | 295 MADISON AVENUE, SUITE 2400, C/O EYENOVIA, INC., NEW YORK NY 10017 |
Mather Charles E Iv | director | C/O TONIX PHARMACEUTICALS HOLDING CORP, 509 MADISON AVE., SUITE 306, NEW YORK NY 10022 |
Tsontcho Ianchulev | director | 501 FIFTH AVENUE, SUITE 1404, NEW YORK NY 10017 |
Stephen Keith Benjamin | director | 135 NORTH CHURCH STREET, SPARTANBURG SC 29306 |
Julia A Haller | director | C/O CELGENE CORPORATION, 86 MORRIS AVENUE, SUMMIT NJ 07901 |
Lee Kenneth B Jr | director | 7100 WEST CREDIT AVENUE, SUITE 101, C/O ARALEZ PHARMACEUTICALS INC., MISSISSAUGA A6 L5N 0E4 |
Curt H Labelle | director | C/O INVESTOR GROWTH CAPITAL, INC., 630 FIFTH AVENUE, SUITE 1965, NEW YORK NY 10011 |
Anthony Y Sun | director | C/O AISLING CAPITAL, 888 SEVENTH AVENUE, 30TH FLOOR, NEW YORK NY 10106 |
Fredric N Eshelman | director | PPD INC, 929 NORTH FRONT STREET, WILMINGTON NC 28401 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.